Home Reagents Clinical Chemistry Reagents Apolipoprotein A-1 (Apo A-1) assay
Quality Guranteed Fast Delivery ad for support

Apolipoprotein A-1 (Apo A-1) assay

Product Method Size Catalog Price Quantity
Apolipoprotein A-1 (Apo A-1) assay Immunoturbidimetric R1 4 x 40ml, R2 4.17ml LP2116 $1318.30
Shipping costs will be added at the checkout stage, click here for charges.
  • Format
    Liquid ready to use
  • Assay Range
    5.78 - 234 mg/dl
  • Working Stability 15-25 °C
  • Working Stability 2-8 °C
    Stable to expiry
Request Kit Insert

Intended Use

For the quantitative in vitro determination of Apolipoprotein A-I (APO A-I) in serum and plasma. For use as an aid in assessing the risk of cardiovascular disease.

Clinical Significance

Lipids are metabolized in the intestine or liver, and are transported to tissues and organs after hydrophilic adaptation by a series of micellar structures. These structures consist of an outer monolayer of protein (an Apo lipoprotein) and polar lipids (phospholipids and unesterified cholesterol) plus an inner core of neutral lipids (triglycerides and cholesterol esters).

The Apo lipoproteins interact with a series of enzymes and tissue receptors and are therefore responsible for further metabolism and catabolism of the micelle.

Just as HDL and LDL are referred to as “good” and “bad” cholesterol, elevated levels of some Apo lipoproteins confer an increased cardiovascular risk while others have a protective effect. Apo lipoproteins are a valuable addition to the lipid profile, supplying further information to researchers and clinicians. The genetic variants of the Apo lipoproteins can have a marked effect on cardiovascular risk and are linked with familial lipoprotein disorders such as hypertriglyceridemia.

Apo lipoproteins and the ratios between them are useful in the assessment of cardiovascular risk in individuals with normal lipoprotein levels. They are also valuable in specific patient populations, for example identifying patients that would benefit from more rigorous treatment in secondary prevention.

The A Apo lipoproteins are the main form of protein found in high density lipoproteins (HDL), although APO A-I is also present in chylomicrons. The main role of APO A-I is in the activation of Lecithin cholesterol acyl transferase (LCAT) and removal of free cholesterol from extra-hepatic tissues. APO A-I may therefore be described as non-atherogenic, showing an inverse relationship to cardiovascular risk.

Studies have shown that there is an inverse relationship between APO A-I and coronary artery disease and a direct relationship with APO B such that patients with CAD have generally reduced levels of APO A-I and increased levels of APO B.


This method is based on the reaction of a sample containing human APO A-I and specific antiserum to form an insoluble complex which can be measured turbidimetrically at 340 nm. By constructing a standard curve from the absorbances of standards the concentration of APO A-I can be determined.